×
Back to Agenda
Session 8: Management of Commercially Confidential Information (CCI) in Clinical Trial Applications (CTA) under the EU Clinical Trial Regulation (CTR)
Session Chair(s)
Lora Killian, MBA
Clinical Trial Transparency and Disclosure Lead, Pfizer, United States
Thomas Schindler, PHD
Director Global Regulatory Affairs - Regulatory Operations, BioNTech SE, Germany
Session 8: Management of Commercially Confidential Information (CCI) in Clinical Trial Applications (CTA) under the EU Clinical Trial Regulation (CTR)
Speaker(s)
Polyana Bastos
Senior Director, Regulatory Law, Actelion Pharmaceuticals, Switzerland
Risks posed by CTIS to the protection of clinical trial innovation
Lora Killian, MBA
Clinical Trial Transparency and Disclosure Lead, Pfizer, United States
CCI management in EU Clinical Trial Applications
Wendy M Wimmer, MS
Director, Clinical Data Disclosure and Transparency, Merck & Co., Inc., United States
CCI management in EU Clinical Trial Applications
Have an account?